miR-30a attenuates cardiac fibrosis in rats with myocardial infarction by inhibiting CTGF

Chen,Liwen; Ji,Qian; Zhu,Hao; Ren,Yizhi; Fan,Zhongguo; Tian,Nailiang

doi:10.3892/etm.2018.5952

miR-30a attenuates cardiac fibrosis in rats with myocardial infarction by inhibiting CTGF

Authors:
- Liwen Chen
- Qian Ji
- Hao Zhu
- Yizhi Ren
- Zhongguo Fan
- Nailiang Tian
View Affiliations

Affiliations: Department of Emergency, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu 210000, P.R. China, Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu 210000, P.R. China
Published online on: March 13, 2018 https://doi.org/10.3892/etm.2018.5952
Pages: 4318-4324
Copyright: © Chen et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The mechanism of miR-30a in myocardial fibrosis in rats with myocardial infarction (MI) was investigated. rAAV9-miR-30a was constructed and transfected to heart via injecting into the left ventricular cavity of MI rats. The sham operation group, control group, miR-30a group and miR‑30a-NC group were established. Besides, the 3'-UTR of CTGF was inserted into luciferase expression plasmid (pMir‑report), then transfected into COS1 cells. miR-30a and control miRNA were, respectively, cotransfected into COS1 cells. The expression of luciferase was detected before and after knockdown of the binding site of miR-30a and the 3'-UTR of CTGF. Four weeks after MI surgery, cardiac function was measured by color Doppler echocardiography, including short axis shortening (FS) and left ventricular ejection fraction (LVEF); the myocardial collagen volume fraction (CVF) was observed by Masson's staining; deposition of collagen I and collagen III were evaluated by immunohistochemical stain; using real-time PCR to detect expression levels of miR-30a and CTGF; the expression of CTGF was observed by western blotting. In MI group, cardiac function was significantly improved, while the expression levels of CVF, collagen I and III, the ratio of type I/III collagen, CTGF were significantly reduced. After knockdown the binding site of miR-30a and the 3'-UTR of CTGF, luciferase expression in COS1 cells decreased significantly. miR-30a might inhibit the expression of CTGF by directly combining with the 3'-UTR site of CTGF after MI, thereby reduce the production of collagen in myocardia, inhibit myocardial fibrosis, then improve cardiac function.

View Figures

View References

1	van Berlo JH, Maillet M and Molkentin JD: Signaling effectors underlying pathologic growth and remodeling of the heart. J Clin Invest. 123:37–45. 2013. View Article : Google Scholar : PubMed/NCBI
2	Chen C, Li R, Ross RS and Manso AM: Integrins and integrin-related proteins in cardiac fibrosis. J Mol Cell Cardiol. 93:162–174. 2016. View Article : Google Scholar : PubMed/NCBI
3	Koshman YE, Patel N, Chu M, Iyengar R, Kim T, Ersahin C, Lewis W, Heroux A and Samarel AM: Regulation of connective tissue growth factor gene expression and fibrosis in human heart failure. J Card Fail. 19:283–294. 2013. View Article : Google Scholar : PubMed/NCBI
4	Creemers EE and van Rooij E: Function and therapeutic potential of non-coding RNAs in cardiac fibrosis. Circ Res. 118:108–118. 2016. View Article : Google Scholar : PubMed/NCBI
5	Li M, Wang N, Zhang J, He HP, Gong HQ, Zhang R, Song TF, Zhang LN, Guo ZX, Cao DS, et al: MicroRNA-29a-3p attenuates ET-1-induced hypertrophic responses in H9c2 cardiomyocytes. Gene. 585:44–50. 2016. View Article : Google Scholar : PubMed/NCBI
6	Zhang Y, Wang R, Du W, Wang S, Yang L, Pan Z, Li X, Xiong X, He H, Shi Y, et al: Downregulation of miR-151-5p contributes to increased susceptibility to arrhythmogenesis during myocardial infarction with estrogen deprivation. PLoS One. 8:e729852013. View Article : Google Scholar : PubMed/NCBI
7	Chen LW, Zhu LL, Ji Q, Zhu H, Ren YZ, Fan ZG, Li XB, Gao XF, Zhang YJ and Tian NL: Relationship between myocardial microRNA-30a expression and myocardial fibrosis in rats post myocardial infarction. Zhonghua Xin Xue Guan Bing Za Zhi. 44:443–449. 2016.(In Chinese). PubMed/NCBI
8	Yuan CT, Li XX, Cheng QJ, Wang YH, Wang JH and Liu CL: MiR-30a regulates the atrial fibrillation-induced myocardial fibrosis by targeting snail 1. Int J Clin Exp Pathol. 8:15527–15536. 2015.PubMed/NCBI
9	Forini F, Kusmic C, Nicolini G, Mariani L, Zucchi R, Matteucci M, Iervasi G and Pitto L: Triiodothyronine prevents cardiac ischemia/reperfusion mitochondrial impairment and cell loss by regulating miR30a/p53 axis. Endocrinology. 155:4581–4590. 2014. View Article : Google Scholar : PubMed/NCBI
10	Gutiérrez-Escolano A, Santacruz-Vázquez E and Gómez-Pérez F: Dysregulated microRNAs involved in contrast-induced acute kidney injury in rat and human. Ren Fail. 37:1498–1506. 2015. View Article : Google Scholar : PubMed/NCBI
11	Yin X, Peng C, Ning W, Li C, Ren Z, Zhang J, Gao H and Zhao K: miR-30a downregulation aggravates pressure overload-induced cardiomyocyte hypertrophy. Mol Cell Biochem. 379:1–6. 2013. View Article : Google Scholar : PubMed/NCBI
12	Gao X, Ma YT, Yang YN, Xiang Y, Chen BD, Liu F and Du L: Recombinant adeno-associated virus serotype 9 transfection of rats H9C2 cells in vitro. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 26:18–20. 2010.(In Chinese). PubMed/NCBI
13	Bish LT, Morine K, Sleeper MM, Sanmiguel J, Wu D, Gao G, Wilson JM and Sweeney HL: Adeno-associated virus (AAV) serotype 9 provides global cardiac gene transfer superior to AAV1, AAV6, AAV7, and AAV8 in the mouse and rat. Hum Gene Ther. 19:1359–1368. 2008. View Article : Google Scholar : PubMed/NCBI
14	Kalisz M, Baranowska B, Wolinska-Witort E, Maczewski M, Mackiewicz U, Tulacz D, Gora M, Martynska L and Bik W: Total and high molecular weight adiponectin levels in the rat model of post-myocardial infarction heart failure. J Physiol Pharmacol. 66:673–680. 2015.PubMed/NCBI
15	Bagno LL, Carvalho D, Mesquita F, Louzada RA, Andrade B, Kasai-Brunswick TH, Lago VM, Suhet G, Cipitelli D, Werneck-de-Castro JP, et al: Sustained IGF-1 secretion by adipose-derived stem cells improves infarcted heart function. Cell Transplant. 25:1609–1622. 2016. View Article : Google Scholar : PubMed/NCBI
16	Chen J, Huang C, Zhang B, Huang Q, Chen J and Xu L: The effects of carvedilol on cardiac structural remodeling: The role of endogenous nitric oxide in the activity of carvedilol. Mol Med Rep. 7:1155–1158. 2013. View Article : Google Scholar : PubMed/NCBI
17	Abdel-Hamid AAM and Firgany A-D: Atorvastatin alleviates experimental diabetic cardiomyopathy by suppressing apoptosis and oxidative stress. J Mol Histol. 46:337–345. 2015. View Article : Google Scholar : PubMed/NCBI
18	Parimala M, Debjani M, Vasanthi HR and Shoba FG: Nymphaea nouchali Burm. f. hydroalcoholic seed extract increases glucose consumption in 3T3-L1 adipocytes through activation of peroxisome proliferator-activated receptor gamma and insulin sensitization. J Adv Pharm Technol Res. 6:183–189. 2015. View Article : Google Scholar : PubMed/NCBI
19	Wojcik B, Harasim E, Zabielski P, Chabowski A and Gorski J: Effect of tachycardia on lipid metabolism and expression of fatty acid transporters in heart ventricles of the rat. J Physiol Pharmacol. 66:691–699. 2015.PubMed/NCBI
20	Pan W, Zhong Y, Cheng C, Liu B, Wang L, Li A, Xiong L and Liu S: MiR-30-regulated autophagy mediates angiotensin II-induced myocardial hypertrophy. PLoS One. 8:e539502013. View Article : Google Scholar : PubMed/NCBI
21	Xia X: The relationship of serum miR-30a and heart failure in children with congenital heart disease. J Clin Pediatr. 32:607–609. 2014.http://www.jcp-sh.org.cn/EN/abstract/abstract8665.shtml
22	Leask A and Abraham DJ: All in the CCN family: Essential matricellular signaling modulators emerge from the bunker. J Cell Sci. 119:4803–4810. 2006. View Article : Google Scholar : PubMed/NCBI
23	Shimo T, Nakanishi T, Nishida T, Asano M, Kanyama M, Kuboki T, Tamatani T, Tezuka K, Takemura M, Matsumura T, et al: Connective tissue growth factor induces the proliferation, migration, and tube formation of vascular endothelial cells in vitro, and angiogenesis in vivo. J Biochem. 126:137–145. 1999. View Article : Google Scholar : PubMed/NCBI
24	Wang B, Haldar SM, Lu Y, Ibrahim OA, Fisch S, Gray S, Leask A and Jain MK: The Kruppel-like factor KLF15 inhibits connective tissue growth factor (CTGF) expression in cardiac fibroblasts. J Mol Cell Cardiol. 45:193–197. 2008. View Article : Google Scholar : PubMed/NCBI
25	Hayata N, Fujio Y, Yamamoto Y, Iwakura T, Obana M, Takai M, Mohri T, Nonen S, Maeda M and Azuma J: Connective tissue growth factor induces cardiac hypertrophy through Akt signaling. Biochem Biophys Res Commun. 370:274–278. 2008. View Article : Google Scholar : PubMed/NCBI
26	Bonniaud P, Martin G, Margetts PJ, Ask K, Robertson J, Gauldie J and Kolb M: Connective tissue growth factor is crucial to inducing a profibrotic environment in ‘fibrosis-resistant’ BALB/c mouse lungs. Am J Respir Cell Mol Biol. 31:510–516. 2004. View Article : Google Scholar : PubMed/NCBI
27	Wang J, Duan L, Guo T, Gao Y, Tian L, Liu J, Wang S and Yang J: Downregulation of miR-30c promotes renal fibrosis by target CTGF in diabetic nephropathy. J Diabetes Complications. 30:406–414. 2016. View Article : Google Scholar : PubMed/NCBI
28	Su Z, Wei G, Wei L, Liu J and Li X: Effects of rhBNP on myocardial fibrosis after myocardial infarction in rats. Int J Clin Exp Pathol. 8:6407–6415. 2015.PubMed/NCBI
29	Duisters RF, Tijsen AJ, Schroen B, Leenders JJ, Lentink V, van der Made I, Herias V, van Leeuwen RE, Schellings MW, Barenbrug P, et al: miR-133 and miR-30 regulate connective tissue growth factor: Implications for a role of microRNAs in myocardial matrix remodeling. Circ Res. 104:170–178. 2009. View Article : Google Scholar : PubMed/NCBI